Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

UCHL1 inhibits ZUP1. 2 / 2

| 2

➶

eidos

"Thus , the finding in this study that UCHL1 / L3 inhibition is not as efficient in blocking viral replication as general inhibition of proteasome function or knockdown of ubiquitin is likely attributed to incomplete inhibition of DUBs by UCHL1 / L3 inhibitors ."

18612413

➶

eidos

"Thus , it is speculated that DUB inhibition by UCHL1 / L3 inhibitors alone , in the absence of apparent inhibition of protein degradation , is not sufficient enough to block viral replication ."

18612413

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...